You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 19, 2024

Cefepime hydrochloride; enmetazobactam - Generic Drug Details

✉ Email this page to a colleague

« Back to Dashboard

What are the generic drug sources for cefepime hydrochloride; enmetazobactam and what is the scope of patent protection?

Cefepime hydrochloride; enmetazobactam is the generic ingredient in one branded drug marketed by Allecra Theraps and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Cefepime hydrochloride; enmetazobactam has twenty-five patent family members in eighteen countries.

One supplier is listed for this compound.

Summary for cefepime hydrochloride; enmetazobactam

International Patents:	25
US Patents:	2
Tradenames:	1
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Clinical Trials:	1
DailyMed Link:	cefepime hydrochloride; enmetazobactam at DailyMed

DrugPatentWatch^® Estimated Loss of Exclusivity (LOE) Date for cefepime hydrochloride; enmetazobactam

Generic Entry Date for cefepime hydrochloride; enmetazobactam^: ⤷ Try a Trial* Constraining patent/regulatory exclusivity: GENERATING ANTIBIOTIC INCENTIVES NOW Dosage: POWDER;INTRAVENOUS

^*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Recent Clinical Trials for cefepime hydrochloride; enmetazobactam

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Linical Co., Ltd.	Phase 2
Allecra	Phase 2

See all cefepime hydrochloride; enmetazobactam clinical trials

Pharmacology for cefepime hydrochloride; enmetazobactam

Drug Class	Cephalosporin Antibacterial

Anatomical Therapeutic Chemical (ATC) Classes for cefepime hydrochloride; enmetazobactam

J01DE	Fourth-generation cephalosporins
J01D	OTHER BETA-LACTAM ANTIBACTERIALS
J01	ANTIBACTERIALS FOR SYSTEMIC USE
J	Antiinfectives for systemic use

US Patents and Regulatory Information for cefepime hydrochloride; enmetazobactam

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Allecra Theraps	EXBLIFEP	cefepime hydrochloride; enmetazobactam	POWDER;INTRAVENOUS	216165-001	Feb 22, 2024		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Allecra Theraps	EXBLIFEP	cefepime hydrochloride; enmetazobactam	POWDER;INTRAVENOUS	216165-001	Feb 22, 2024		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Allecra Theraps	EXBLIFEP	cefepime hydrochloride; enmetazobactam	POWDER;INTRAVENOUS	216165-001	Feb 22, 2024		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Allecra Theraps	EXBLIFEP	cefepime hydrochloride; enmetazobactam	POWDER;INTRAVENOUS	216165-001	Feb 22, 2024		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial	Y	Y		⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for cefepime hydrochloride; enmetazobactam

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Title	Estimated Expiration
Japan	2021102642	結晶性β−ラクタマーゼ阻害剤 (CRYSTALLINE β-LACTAMASE INHIBITOR)	⤷ Try a Trial
Cyprus	1114927		⤷ Try a Trial
China	105873935	结晶的β-内酰胺酶抑配制品 (Crystalline beta-lactamase inhibitor)	⤷ Try a Trial
European Patent Office	3066103	INHIBITEUR CRISTALLIN DE BÊTA-LACTAMASE (CRYSTALLINE BETA-LACTAMASE INHIBITOR)	⤷ Try a Trial
Peru	20160890	INHIBIDOR DE BETA-LACTAMASA CRISTALINA	⤷ Try a Trial
Denmark	2046802		⤷ Try a Trial
European Patent Office	2046802	DÉRIVÉS 2-SUBSTITUÉS DU MÉTHYL PÉNAM (2-SUBSTITUTED METHYL PENAM DERIVATIVES)	⤷ Try a Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.